The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insulin Drug and Delivery Technologies Market Research Report 2024
Synopsis
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The global Insulin Drug and Delivery Technologies market was valued at US$ 32570 million in 2023 and is anticipated to reach US$ 61720 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insulin Drug and Delivery Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Drug and Delivery Technologies.
Report Scope
The Insulin Drug and Delivery Technologies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Drug and Delivery Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Drug and Delivery Technologies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Drug and Delivery Technologies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Drug and Delivery Technologies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The global Insulin Drug and Delivery Technologies market was valued at US$ 32570 million in 2023 and is anticipated to reach US$ 61720 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Insulin Drug and Delivery Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Drug and Delivery Technologies.
Report Scope
The Insulin Drug and Delivery Technologies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Drug and Delivery Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Drug and Delivery Technologies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Drug and Delivery Technologies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Drug and Delivery Technologies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Insulin Drug and Delivery Technologies Market Overview
1.1 Product Overview and Scope of Insulin Drug and Delivery Technologies
1.2 Insulin Drug and Delivery Technologies Segment by Type
1.2.1 Global Insulin Drug and Delivery Technologies Market Value Comparison by Type (2024-2030)
1.2.2 Insulin Syringes
1.2.3 Insulin Vials
1.2.4 Insulin Pens
1.2.5 Insulin Pumps
1.3 Insulin Drug and Delivery Technologies Segment by Application
1.3.1 Global Insulin Drug and Delivery Technologies Market Value by Application: (2024-2030)
1.3.2 Diabetes Mellitus Type 1
1.3.3 Diabetes Mellitus Type 2
1.3.4 Gestational Diabetes
1.4 Global Insulin Drug and Delivery Technologies Market Size Estimates and Forecasts
1.4.1 Global Insulin Drug and Delivery Technologies Revenue 2019-2030
1.4.2 Global Insulin Drug and Delivery Technologies Sales 2019-2030
1.4.3 Global Insulin Drug and Delivery Technologies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Drug and Delivery Technologies Market Competition by Manufacturers
2.1 Global Insulin Drug and Delivery Technologies Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Drug and Delivery Technologies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Drug and Delivery Technologies Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Drug and Delivery Technologies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Drug and Delivery Technologies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Drug and Delivery Technologies, Product Type & Application
2.7 Insulin Drug and Delivery Technologies Market Competitive Situation and Trends
2.7.1 Insulin Drug and Delivery Technologies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Drug and Delivery Technologies Players Market Share by Revenue
2.7.3 Global Insulin Drug and Delivery Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Drug and Delivery Technologies Retrospective Market Scenario by Region
3.1 Global Insulin Drug and Delivery Technologies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Drug and Delivery Technologies Global Insulin Drug and Delivery Technologies Sales by Region: 2019-2030
3.2.1 Global Insulin Drug and Delivery Technologies Sales by Region: 2019-2024
3.2.2 Global Insulin Drug and Delivery Technologies Sales by Region: 2025-2030
3.3 Global Insulin Drug and Delivery Technologies Global Insulin Drug and Delivery Technologies Revenue by Region: 2019-2030
3.3.1 Global Insulin Drug and Delivery Technologies Revenue by Region: 2019-2024
3.3.2 Global Insulin Drug and Delivery Technologies Revenue by Region: 2025-2030
3.4 North America Insulin Drug and Delivery Technologies Market Facts & Figures by Country
3.4.1 North America Insulin Drug and Delivery Technologies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Drug and Delivery Technologies Sales by Country (2019-2030)
3.4.3 North America Insulin Drug and Delivery Technologies Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Drug and Delivery Technologies Market Facts & Figures by Country
3.5.1 Europe Insulin Drug and Delivery Technologies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Drug and Delivery Technologies Sales by Country (2019-2030)
3.5.3 Europe Insulin Drug and Delivery Technologies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Drug and Delivery Technologies Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Drug and Delivery Technologies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Drug and Delivery Technologies Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Drug and Delivery Technologies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Drug and Delivery Technologies Market Facts & Figures by Country
3.7.1 Latin America Insulin Drug and Delivery Technologies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Drug and Delivery Technologies Sales by Country (2019-2030)
3.7.3 Latin America Insulin Drug and Delivery Technologies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Drug and Delivery Technologies Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Drug and Delivery Technologies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Drug and Delivery Technologies Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Drug and Delivery Technologies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Drug and Delivery Technologies Sales by Type (2019-2030)
4.1.1 Global Insulin Drug and Delivery Technologies Sales by Type (2019-2024)
4.1.2 Global Insulin Drug and Delivery Technologies Sales by Type (2025-2030)
4.1.3 Global Insulin Drug and Delivery Technologies Sales Market Share by Type (2019-2030)
4.2 Global Insulin Drug and Delivery Technologies Revenue by Type (2019-2030)
4.2.1 Global Insulin Drug and Delivery Technologies Revenue by Type (2019-2024)
4.2.2 Global Insulin Drug and Delivery Technologies Revenue by Type (2025-2030)
4.2.3 Global Insulin Drug and Delivery Technologies Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Drug and Delivery Technologies Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Drug and Delivery Technologies Sales by Application (2019-2030)
5.1.1 Global Insulin Drug and Delivery Technologies Sales by Application (2019-2024)
5.1.2 Global Insulin Drug and Delivery Technologies Sales by Application (2025-2030)
5.1.3 Global Insulin Drug and Delivery Technologies Sales Market Share by Application (2019-2030)
5.2 Global Insulin Drug and Delivery Technologies Revenue by Application (2019-2030)
5.2.1 Global Insulin Drug and Delivery Technologies Revenue by Application (2019-2024)
5.2.2 Global Insulin Drug and Delivery Technologies Revenue by Application (2025-2030)
5.2.3 Global Insulin Drug and Delivery Technologies Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Drug and Delivery Technologies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Insulin Drug and Delivery Technologies Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly and Company Insulin Drug and Delivery Technologies Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biocon Insulin Drug and Delivery Technologies Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Julphar
6.4.1 Julphar Corporation Information
6.4.2 Julphar Description and Business Overview
6.4.3 Julphar Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Julphar Insulin Drug and Delivery Technologies Product Portfolio
6.4.5 Julphar Recent Developments/Updates
6.5 Ypsomed
6.5.1 Ypsomed Corporation Information
6.5.2 Ypsomed Description and Business Overview
6.5.3 Ypsomed Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ypsomed Insulin Drug and Delivery Technologies Product Portfolio
6.5.5 Ypsomed Recent Developments/Updates
6.6 Becton, Dickinson and Company
6.6.1 Becton, Dickinson and Company Corporation Information
6.6.2 Becton, Dickinson and Company Description and Business Overview
6.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Product Portfolio
6.6.5 Becton, Dickinson and Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Drug and Delivery Technologies Industry Chain Analysis
7.2 Insulin Drug and Delivery Technologies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Drug and Delivery Technologies Production Mode & Process
7.4 Insulin Drug and Delivery Technologies Sales and Marketing
7.4.1 Insulin Drug and Delivery Technologies Sales Channels
7.4.2 Insulin Drug and Delivery Technologies Distributors
7.5 Insulin Drug and Delivery Technologies Customers
8 Insulin Drug and Delivery Technologies Market Dynamics
8.1 Insulin Drug and Delivery Technologies Industry Trends
8.2 Insulin Drug and Delivery Technologies Market Drivers
8.3 Insulin Drug and Delivery Technologies Market Challenges
8.4 Insulin Drug and Delivery Technologies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
